ARWR
Arrowhead Pharmaceuticals, Inc.
NASDAQ · USHealthcareBiotechnology
$71.65-3.57%
Price as of Jul 20, 2026
ARWR analysis
Arrowhead Pharmaceuticals, Inc. stock analysis
Published Drillr research and company-specific analysis. Existing articles keep their current URLs and citation behavior.
Analysis for ARWR is not published yet
Browse the public research library while company-specific analysis is being prepared. Explore research